Las Vegas, NV -- (SBWIRE) -- 10/09/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: OmniVision Technologies, Inc. (NASDAQ:OVTI), Organovo Holdings Inc (NYSEMKT: ONVO), Immunomedics, Inc. (NASDAQ:IMMU), Monster Worldwide, Inc. (NYSE:MWW)
OmniVision Technologies, Inc. (NASDAQ:OVTI) managed to keep its fall at -5.30% on above-normal volume of 2.21M shares. The stock settled at $14.11 after floating in a range of $14.11 to $15.01. Its latest price has reached market capitalization of $783.68 million. Its 52-week range has been $12.06 to $20.48. OmniVision Technologies, Inc. engages in designing, developing, and marketing semiconductor image-sensor devices worldwide.
Has OVTI Found The Bottom and Ready To Move Up? Find Out Here
Organovo Holdings Inc (NYSEMKT: ONVO) traded down on a volume of 2.19 million, higher than its standard daily volume. Shares have dropped-5.98% to $5.66. Over the last twelve months, the stock has gained 185.86% and faced a worst price of $1.80. Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company?s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern.
Has ONVO Found The Bottom And Ready To Gain Momentum? Find Out Here
Immunomedics, Inc. (NASDAQ:IMMU) settled -11.85% lower at $5.95 on above-normal volume of 2.18M shares during the last trading day. The stock has its 12-month high at $7.35 and 52-week low price was $2.11. It traded in a range of $5.95 to $6.77 during the last trading day. Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases. Its products include epratuzumab, which is in two Phase III clinical trials for the treatment of lupus.
Will IMMU Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Monster Worldwide, Inc. (NYSE:MWW) was down on low volume, trading at a volume of 2.18M versus its average daily volume of 2.89 million shares. At $4.12, the stock has attained market capitalization of 456.70 million. Monster Worldwide, Inc., together with its subsidiaries, provides online and mobile employment solutions worldwide.
Why Should Investors Buy MWW After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)